Biomarin Pharmaceutical (BMRN) Assets (2009 - 2026)
Biomarin Pharmaceutical (BMRN) posted Assets of $8.6 billion for Q1 2026, up 13.13% on a QoQ basis from $7.6 billion in Q4 2025, and up 20.2% year-over-year from $7.1 billion in Q1 2025.
Biomarin Pharmaceutical (BMRN) Assets (2009 - 2026) Analysis & Trends
Biomarin Pharmaceutical's Assets history runs 18 years deep, the most recent figure standing at $8.6 billion for Q1 2026.
- Quarterly Assets rose 20.2% year-over-year to $8.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 billion (up 20.2% YoY) and the FY2025 annual result came in at $7.6 billion, up 8.66% from the prior year.
- Assets was $8.6 billion for Q1 2026 at Biomarin Pharmaceutical, up from $7.6 billion in the prior quarter.
- Across five years, Assets topped out at $8.6 billion in Q1 2026 and bottomed at $6.1 billion in Q1 2022.
- A 5-year average of $6.9 billion and a median of $6.9 billion in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2024 — Assets rose 1.38% — and 2026, when it gained 20.2%.
- Biomarin Pharmaceutical's Assets stood at $6.4 billion in 2022, then increased by 7.32% to $6.8 billion in 2023, then rose by 2.15% to $7.0 billion in 2024, then advanced by 8.66% to $7.6 billion in 2025, then climbed by 13.13% to $8.6 billion in 2026.
- Business Quant data shows BMRN's Assets at $8.6 billion in Q1 2026, $7.6 billion in Q4 2025, and $7.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn | 8.59 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.59 Bn |
| Dec 31, 2025 | 7.59 Bn |
| Sep 30, 2025 | 7.61 Bn |
| Jun 30, 2025 | 7.46 Bn |
| Mar 31, 2025 | 7.15 Bn |
| Dec 31, 2024 | 6.99 Bn |
| Sep 30, 2024 | 6.85 Bn |
| Jun 30, 2024 | 7.07 Bn |
| Mar 31, 2024 | 6.87 Bn |
| Dec 31, 2023 | 6.84 Bn |
| Sep 30, 2023 | 6.76 Bn |
| Jun 30, 2023 | 6.56 Bn |
| Mar 31, 2023 | 6.43 Bn |
| Dec 31, 2022 | 6.38 Bn |
| Sep 30, 2022 | 6.26 Bn |
| Jun 30, 2022 | 6.15 Bn |
| Mar 31, 2022 | 6.06 Bn |
| Dec 31, 2021 | 6.00 Bn |
| Sep 30, 2021 | 5.98 Bn |
| Jun 30, 2021 | 5.90 Bn |